19:22 IST
BSE
Results Update
Jubilant Pharmova Results Update
Jubilant Pharmova reported Q1 FY27 revenue of ₹2,229 Crore, reflecting 17% YoY growth. Net profit stood at ₹56 Crore amidst margin impacts.
Jubilant Pharmova Ltd
- Share price
- ₹975.00
- Market cap
- ₹15,530 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 44.1×Sector 47.4×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 6Annual General Meeting 4Other Announcement 3Financial Results 3Board Meeting Outcome 3Results Update 2Business Update 2Production Started 1Management Change 1Employee Stock Options 1Earnings Call 1Dividend 1Board Meeting Date 1
Time
2 announcements with these filters
14:52 IST
NSE
Results Update
Jubilant Pharmova Results Update
Jubilant Pharmova reported FY26 revenue of ₹8,280 Crore, a 14% YoY increase. Growth was driven by the CDMO Sterile Injectables segment and expanded Ruby-Fill® installations.
- Value
- ₹8,280 Cr